Golden Throat successfully coughs up $108m IPO

The Chinese throat lozenges maker overcame turbulent markets to complete its Hong Kong IPO after trading in a quarter of A-share-listed companies was suspended.

Chinese lozenges maker Golden Throat overcame testing market conditions on Tuesday to successfully price its initial public offering in Hong Kong, albeit near the bottom of its indicative range as Chinese share worries continued to swirl.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media